RxDoctor Payments Data

Christine Shaw

Physician Assistant · Springfield, ILNPI 1083270938

Payments from drug & device makers

$420in general payments, 2019–2025

Across 22 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$112
  • Novartis$68
  • Johnson & Johnson$51
  • Corcept Therapeutics$40
  • Boehringer Ingelheim$39
  • Novo Nordisk$26
  • plus $84 from 5 others

What the payments were for

  • Food & beverage$420100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$420 in reported general payments places this provider in the 60th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$57,211
Medicare patients
199
Services billed
1,719

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide69$83,478
OzempicSemaglutide36$70,470
JardianceEmpagliflozin50$61,456
FarxigaDapagliflozin Propanediol27$32,843
Tresiba Flextouch U-100Insulin Degludec34$28,143
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$23,168
Humulin R U-500 KwikpenInsulin Regular, Human15$21,917
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog35$21,041
TrulicityDulaglutide12$19,249
Lantus SolostarInsulin Glargine,hum.Rec.Anlog103$17,284
Fiasp FlextouchInsulin Aspart (Niacinamide)18$16,987
Novolog FlexpenInsulin Aspart52$13,792
Humalog Kwikpen U-100Insulin Lispro41$13,432
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$12,175
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/714$10,380

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$26$70,47036 claims
Boehringer IngelheimJardiance$39$61,45650 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →